| Deaths attributable to carbapenem-resistant Enterobacteriaceae infections ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas Emerging infectious diseases 20 (7), 1170, 2014 | 611 | 2014 |
| Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence ME Falagas, P Lourida, P Poulikakos, PI Rafailidis, GS Tansarli Antimicrobial agents and chemotherapy 58 (2), 654-663, 2014 | 444 | 2014 |
| Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta … KZ Vardakas, GS Tansarli, PI Rafailidis, ME Falagas Journal of antimicrobial chemotherapy 67 (12), 2793-2803, 2012 | 440 | 2012 |
| Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis ME Falagas, GS Tansarli, K Ikawa, KZ Vardakas Clinical infectious diseases 56 (2), 272-282, 2013 | 369 | 2013 |
| Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis GS Tansarli, KC Chapin Clinical Microbiology and Infection 26 (3), 281-290, 2020 | 200 | 2020 |
| Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a … P Poulikakos, GS Tansarli, ME Falagas European journal of clinical microbiology & infectious diseases 33, 1675-1685, 2014 | 134 | 2014 |
| β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis KZ Vardakas, GS Tansarli, IA Bliziotis, ME Falagas International journal of antimicrobial agents 41 (4), 301-310, 2013 | 130 | 2013 |
| Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence GS Tansarli, DE Karageorgopoulos, A Kapaskelis, ME Falagas Expert review of anti-infective therapy 11 (3), 321-331, 2013 | 130 | 2013 |
| Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections ME Falagas, KZ Vardakas, KP Tsiveriotis, NA Triarides, GS Tansarli International journal of antimicrobial agents 44 (1), 1-7, 2014 | 126 | 2014 |
| Antimicrobial-impregnated and-coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis AA Konstantelias, KZ Vardakas, KA Polyzos, GS Tansarli, ME Falagas Journal of neurosurgery 122 (5), 1096-1112, 2015 | 114 | 2015 |
| Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults GS Tansarli, E Mylonakis Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00635-18, 2018 | 113 | 2018 |
| Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity GS Tansarli, EK Kostaras, S Athanasiou, ME Falagas European journal of clinical microbiology & infectious diseases 32, 977-984, 2013 | 106 | 2013 |
| Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence—systematic review GS Tansarli, P Poulikakos, A Kapaskelis, ME Falagas Journal of Antimicrobial Chemotherapy 69 (5), 1177-1184, 2014 | 105 | 2014 |
| A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies G Samonis, KZ Vardakas, S Maraki, GS Tansarli, D Dimopoulou, ... Supportive Care in Cancer 21, 2521-2526, 2013 | 88 | 2013 |
| Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis ME Falagas, GS Tansarli, PI Rafailidis, A Kapaskelis, KZ Vardakas Antimicrobial agents and chemotherapy 56 (8), 4214-4222, 2012 | 75 | 2012 |
| Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg− mothers: a systematic review and meta-analysis M Machaira, V Papaevangelou, EK Vouloumanou, GS Tansarli, ... Journal of Antimicrobial Chemotherapy 70 (2), 396-404, 2015 | 71 | 2015 |
| Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa GS Tansarli, S Athanasiou, ME Falagas Antimicrobial agents and chemotherapy 57 (8), 3628-3639, 2013 | 68 | 2013 |
| Impact of vacuum-assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta-analysis of non-randomized studies ME Falagas, GS Tansarli, A Kapaskelis, KZ Vardakas PLoS One 8 (5), e64741, 2013 | 61 | 2013 |
| Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta … MN Mavros, GS Tansarli, KZ Vardakas, PI Rafailidis, ... International journal of antimicrobial agents 40 (6), 496-509, 2012 | 59 | 2012 |
| Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials ME Falagas, AKA Karagiannis, T Nakouti, GS Tansarli PLoS One 10 (1), e0116207, 2015 | 53 | 2015 |
Matthew FalagasAlfa Institute Biomedical Sciences & Hygeia Hospital, Greece & Tufts Univ. Sch. Medicine, Boston, MAΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα aibs.gr
